Acalabrutinib and Its Therapeutic Potential in the Treatment of Chronic Lymphocytic Leukemia: A Short Review on Emerging Data

Isaac K, Mato AR

Cancer Management and Research 2020, 12:2079-2085

Published Date: 19 March 2020